Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
24.81
+0.73 (3.03%)
At close: Sep 12, 2025, 4:00 PM EDT
24.16
-0.65 (-2.62%)
After-hours: Sep 12, 2025, 5:19 PM EDT
Sol-Gel Technologies Market Cap
Sol-Gel Technologies has a market cap or net worth of $69.12 million as of September 12, 2025. Its market cap has increased by 310.77% in one year.
Market Cap
69.12M
Enterprise Value
47.36M
1-Year Change
310.77%
Ranking
Category
Stock Price
$24.81
Market Cap Chart
Since February 1, 2018, Sol-Gel Technologies's market cap has decreased from $245.32M to $69.12M, a decrease of -71.83%. That is a compound annual growth rate of -15.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 69.12M | 166.75% |
| Dec 31, 2024 | 25.91M | -15.83% |
| Dec 29, 2023 | 30.78M | -70.81% |
| Dec 30, 2022 | 105.47M | -38.35% |
| Dec 31, 2021 | 171.08M | -24.02% |
| Dec 31, 2020 | 225.18M | -35.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.94B |
| Johnson & Johnson | 429.89B |
| AbbVie | 389.03B |
| UnitedHealth Group | 320.26B |
| AstraZeneca | 251.66B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 230.87B |